Péter Boross

4.5k citations

79 papers · 3.6k indexed · h-index 38

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 38
- Monoclonal and Polyclonal Antibodies Research 37
Immunology 37
- T-cell and B-cell Immunology 16
- T-cell and Retrovirus Studies 8
- Immune Cell Function and Interaction 7

Co-authors: Jeanette H.W. Leusen (21 shared papers)Irene T. Weber (22 shared papers)József Tőzsér (29 shared papers)Robert W. Harrison (13 shared papers)Yunfeng Tie (8 shared papers)Arun K. Ghosh (7 shared papers)J.H. Marco Jansen (12 shared papers)Yuan‐Fang Wang (8 shared papers)
Journals: The Journal of Immunology (9 papers)Journal of Molecular Biology (5 papers)mAbs (4 papers)European Journal of Biochemistry (4 papers)Journal of Biological Chemistry (3 papers)
Partner nations: Netherlands Hungary United States

In The Last Decade

Péter Boross

78 papers receiving 3.5k citations

Peers

Countries citing papers authored by Péter Boross

Since Specialization

Citations

This map shows the geographic impact of Péter Boross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Boross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Boross more than expected).

Fields of papers citing papers by Péter Boross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Boross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Boross. The network helps show where Péter Boross may publish in the future.

Co-authors

The 25 scholars most cited alongside Péter Boross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Péter Boross Line = papers co-authored together Péter Boross links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Novel bis -Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro Antimicrobial Agents and Chemotherapy ·Yasuhiro Koh, Hirotomo Nakata, Kenji Maeda, Hiromi Ogata, Geoffrey Bilcer, Thippeswamy Devasamudram, John Kincaid, Péter Boross, Yuan-Fang Wang, Yunfeng Tie, Patra Volarath, L. Gaddis, Robert W. Harrison, Irene T. Weber, Arun K. Ghosh, Hiroaki Mitsuya	2003	302
2	The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor–Mediated Cross-Linking The Journal of Immunology ·Marije B. Overdijk, J.H. Marco Jansen, Maaike Nederend, Jeroen J. Lammerts van Bueren, Richard W.J. Groen, Paul W.H.I. Parren, Jeanette H.W. Leusen, Péter Boross	2016	196
3	Mechanisms of action of CD20 antibodies. PubMed ·Péter Boross, Jeanette H.W. Leusen	2012	196
4	High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical Strains Journal of Molecular Biology ·Yunfeng Tie, Péter Boross, Yuan‐Fang Wang, L. Gaddis, Azhar K. Hussain, Sofiya Leshchenko, Arun K. Ghosh, John M. Louis, Robert W. Harrison, Irene T. Weber	2004	185
5	Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement Journal of Controlled Release ·Mariona Estapé Sentí, Caroline A. de Jongh, Kim Dijkxhoorn, J. Verhoef, János Szebeni, Gert Storm, C. Erik Hack, Raymond M. Schiffelers, Marcel H.A.M. Fens, Péter Boross	2021	124
6	Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy Journal of Proteomics ·Éva Csősz, Péter Boross, Adrienne Csutak, András Berta, Ferenc Tóth, Szilárd Póliska, Zsolt Török, József Tőzsér	2012	122
7	Effectiveness of Nonpeptide Clinical Inhibitor TMC-114 on HIV-1 Protease with Highly Drug Resistant Mutations D30N, I50V, and L90M Journal of Medicinal Chemistry ·Andrey Kovalevsky, Yunfeng Tie, Fengling Liu, Péter Boross, Yuan‐Fang Wang, Sofiya Leshchenko, Arun K. Ghosh, Robert W. Harrison, Irene T. Weber	2006	114
8	Ig A EGFR antibodies mediate tumour killing in vivo EMBO Molecular Medicine ·Péter Boross, Stefan Lohse, Maaike Nederend, J.H. Marco Jansen, Geert van Tetering, Michael Dechant, Matthias Peipp, Louise Royle, Li Phing Liew, Louis Boon, Nico van Rooijen, Wim K. Bleeker, Paul W.H.I. Parren, Jan G. J. van de Winkel, Thomas Valerius, Jeanette H.W. Leusen	2013	101
9	Identification of Cytoplasmic Actin as an Abundant Glutaminyl Substrate for Tissue Transglutaminase in HL-60 and U937 Cells Undergoing Apoptosis Journal of Biological Chemistry ·Zoltán Nemes, Róza Ádány, Margit Balázs, Péter Boross, László Fésüs	1997	100
10	In vivo Cytotoxicity of Type I CD20 Antibodies Critically Depends on Fc Receptor ITAM Signaling Cancer Research ·Simone de Haij, J.H. Marco Jansen, Péter Boross, Frank J. Beurskens, Jantine E. Bakema, Desirée L. Bos, Anton C. Martens, J. Sjef Verbeek, Paul W.H.I. Parren, Jan G. J. van de Winkel, Jeanette H.W. Leusen	2010	98
11	The Inhibiting Fc Receptor for IgG, FcγRIIB, Is a Modifier of Autoimmune Susceptibility The Journal of Immunology ·Péter Boross, Victoria L. Arandhara, Javier Martín-Ramírez, Marie-Laure Santiago-Raber, Francesco Carlucci, Roelof Flierman, Jos van der Kaa, Cor Breukel, Jill Claassens, Marcel Camps, Erik Lubberts, Daniela Salvatori, Maria Pia Rastaldi, Ferry Ossendorp, Mohamed R. Daha, H. Terence Cook, Shozo Izui, Marina Botto, J. Sjef Verbeek	2011	88
12	Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer mAbs ·Saskia Meyer, Jeanette H.W. Leusen, Péter Boross	2014	85
13	Atomic resolution crystal structures of HIV‐1 protease and mutants V82A and I84V with saquinavir Proteins Structure Function and Bioinformatics ·Yunfeng Tie, Andrey Kovalevsky, Péter Boross, Yuan‐Fang Wang, Arun K. Ghosh, József Tőzsér, Robert W. Harrison, Irene T. Weber	2007	77
14	Effect of sequence polymorphism and drug resistance on two HIV‐1 Gag processing sites European Journal of Biochemistry ·Anita Fehér, Irene T. Weber, Péter Bagossi, Péter Boross, Bhuvaneshwari Mahalingam, John M. Louis, Terry D. Copeland, I. Yu. Torshin, Robert W. Harrison, József Tőzsér	2002	66
15	Kinetic, Stability, and Structural Changes in High-resolution Crystal Structures of HIV-1 Protease with Drug-resistant Mutations L24I, I50V, and G73S Journal of Molecular Biology ·Fengling Liu, Péter Boross, Yuan-Fang Wang, József Tőzsér, John M. Louis, Robert W. Harrison, Irene T. Weber	2005	64
16	Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir‐binding site European Journal of Biochemistry ·Bhuvaneshwari Mahalingam, Yuan‐Fang Wang, Péter Boross, József Tőzsér, John M. Louis, Robert W. Harrison, Irene T. Weber	2004	62
17	Structural and Kinetic Analysis of Caspase-3 Reveals Role for S5 Binding Site in Substrate Recognition Journal of Molecular Biology ·Bin Fang, Péter Boross, József Tőzsér, Irene T. Weber	2006	61
18	Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 Å resolution crystal structures of HIV‐1 protease mutants with substrate analogs FEBS Journal ·Yunfeng Tie, Péter Boross, Yuan‐Fang Wang, L. Gaddis, Fengling Liu, Xianfeng Chen, József Tőzsér, Robert W. Harrison, Irene T. Weber	2005	61
19	A Novel Bis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI), GRL-98065, Is Potent against Multiple-PI-Resistant Human Immunodeficiency Virus In Vitro Antimicrobial Agents and Chemotherapy ·Masayuki Amano, Yasuhiro Koh, Debananda Das, Jianfeng Li, Sofiya Leschenko, Yuan-Fang Wang, Péter Boross, Irene T. Weber, Arun K. Ghosh, Hiroaki Mitsuya	2007	59
20	Coordinate expression of activating Fcγ receptors I and III and inhibiting Fcγ receptor type II in the determination of joint inflammation and cartilage destruction during immune complex–mediated arthritis Arthritis & Rheumatism ·Karin C. Nabbe, Arjen B. Blom, A. E. M. Holthuysen, Péter Boross, Johannes Roth, S. Verbeek, Peter L. E. M. van Lent, Wim B. van den Berg	2003	58

About Péter Boross

Péter Boross is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology, Virology and Infectious Diseases, having authored 79 papers that have together received 3.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (37 papers), HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (19 papers), T-cell and B-cell Immunology (16 papers), Glycosylation and Glycoproteins Research (16 papers), T-cell and Retrovirus Studies (8 papers), Immune Cell Function and Interaction (7 papers) and Animal Disease Management and Epidemiology (7 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.2k citations), Immunology (1.2k citations), Radiology, Nuclear Medicine and Imaging (993 citations) and Hematology (284 citations). Péter Boross has collaborated with scholars based in Netherlands, Hungary and United States. Frequent co-authors include Jeanette H.W. Leusen, Irene T. Weber, József Tőzsér, Robert W. Harrison, Yunfeng Tie, Arun K. Ghosh, J.H. Marco Jansen, Yuan‐Fang Wang, John M. Louis and Paul W.H.I. Parren. Their work appears in journals such as The Journal of Immunology, Journal of Molecular Biology, mAbs, European Journal of Biochemistry and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact